comparemela.com

Latest Breaking News On - Sourcei peace inc - Page 1 : comparemela.com

GMP cell CDMO I Peace, Inc obtains accreditation as ISO 17025: 2017 compliant

/PRNewswire/ Leading GMP cell CDMO I Peace, Inc. (https://www.ipeace.com), specializing in induced pluripotent stem cells (iPSCs) and iPSC-derived cell.

Palo altoUnited statesShinya yamanakaKoji tanabeSourcei peace incCdmoi peace incI peace incI peace ltdKyoto universityNational accreditation boardAccreditation boardPeace palo altoProfessor shinya yamanakaPeace engine kyotoPi peaceHealth care amp hospitals

Using iPS Cells from I Peace, Heartseed Succeeds in Stable Production of High Purity Cardiomyocytes, A Major Step Forward in Advancing Autologous Cardiac Regenerative Medicine

/PRNewswire/ Leading GMP cell CDMO I Peace, Inc. (https://www.ipeace.com), specializing in induced pluripotent stem cells (iPSCs) and iPSC-derived cell.

Palo altoUnited statesShinya yamanakaKeiichi fukudaNovo nordiskKoji tanabeMinistry of educationI peace incCdmoi peace incKyoto universityTechnology award at academic startupsDepartment of cardiologyTechnology policy award at japan ventureSourcei peace incKeio universityI peace ltd

I Peace, Inc honored in BioSpectrum Asia Excellence Award 2022 with Special Recognition in Cell Therapy

/PRNewswire/ I Peace, Inc. (https://www.ipeace.com), has been awarded a "Special Recognition in Cell Therapy" during BioSpectrum Asia Excellence Award 2022.

United statesPalo altoShinya yamanakaKoji tanabePrnewswirei peace incJapan ministry of healthKyoto universityI peace incSourcei peace incBiospectrum asia excellence awardPalo alto basedNobel prize winningPeace engine kyotoPi peace

I Peace partners with the California Institute for Regenerative Medicine [CIRM]

/PRNewswire/ I Peace, Inc. (https://www.ipeace.com) announced that the company has agreed to join the California Institute for Regenerative Medicine s.

United statesPalo altoShinya yamanakaKoji tanabeCalifornia institute for regenerative medicineKyoto universityI peace incJapan ministry of healthIndustry resource partner programSourcei peace incI peace ltdCalifornia instituteRegenerative medicineGood manufacturing practicePluripotent stem cellsClinical stage

GMP cell CDMO I Peace, Inc in collaboration with universities successfully converted human dermal fibroblasts into oligodendrocyte by direct reprogramming

/PRNewswire/ Koji Tanabe of I Peace, Inc. (https://www.ipeace.com) and a researcher Hiroko Nobuta of the University of California, San Francisco (currently.

United statesRutgers universityNew jerseyPalo altoSan franciscoShinya yamanakaKoji tanabeHiroko nobutaUniversity of californiaDevelopment onKyoto universityI peace incSourcei peace incWernig at sanford universityI peace ltdSanford university

vimarsana © 2020. All Rights Reserved.